Vimarsana
Biggest News Aggregation in the World

Page 3 - Breakthrough Device Designations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Device Designations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Device Designations Today - Breaking & Trending Today

ONWARD® Medical Submits De Novo Application to FDA for its - Vimarsana News

ONWARD® Medical Submits De Novo Application to FDA for its

ONWARD Medical has submitted its De Novo application to the US Food and Drug Administration (FDA) to allow marketing of its breakthrough ARC-EX System. ...

ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System - Vimarsana News

ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System

FDA clearance would allow the Company to market its breakthrough therapy to improve or restore hand and arm function after spinal cord injury in the USTHIS PRESS RELEASE CONTAINS INSIDE INFORMATION...

ONWARD® Medical Publishes Closing of Accelerated Bookbuild Offering and Public Offering in France - Vimarsana News

ONWARD® Medical Publishes Closing of Accelerated Bookbuild Offering and Public Offering in France

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL....

ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System - Vimarsana News

ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System

The Company is one of the first brain-computer interface entrants accepted into this program, intended to optimize the commercialization pathway for breakthrough medical technology EINDHOVEN, the...

KBC Securities Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 10.00 Per Share - Vimarsana News

KBC Securities Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 10.00 Per Share

EINDHOVEN, the Netherlands, Feb. 09, 2024 -- ONWARD Medical N.V. , the medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal...